nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCB1—ovarian cancer	0.241	1	CbGaD
Venlafaxine—ABCG2—Topotecan—ovarian cancer	0.0979	0.203	CbGbCtD
Venlafaxine—ABCG2—Paclitaxel—ovarian cancer	0.0485	0.101	CbGbCtD
Venlafaxine—ABCG2—Carboplatin—ovarian cancer	0.0456	0.0948	CbGbCtD
Venlafaxine—ABCB1—Topotecan—ovarian cancer	0.0353	0.0734	CbGbCtD
Venlafaxine—ABCG2—Docetaxel—ovarian cancer	0.035	0.0728	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—ovarian cancer	0.0261	0.0543	CbGbCtD
Venlafaxine—ABCB1—Vinorelbine—ovarian cancer	0.0249	0.0517	CbGbCtD
Venlafaxine—CYP2D6—Vinorelbine—ovarian cancer	0.0234	0.0487	CbGbCtD
Venlafaxine—CYP3A4—Topotecan—ovarian cancer	0.0212	0.0439	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—ovarian cancer	0.0184	0.0382	CbGbCtD
Venlafaxine—CYP2C9—Paclitaxel—ovarian cancer	0.018	0.0374	CbGbCtD
Venlafaxine—ABCB1—Paclitaxel—ovarian cancer	0.0175	0.0363	CbGbCtD
Venlafaxine—CYP3A4—Vinorelbine—ovarian cancer	0.0149	0.031	CbGbCtD
Venlafaxine—ABCB1—Docetaxel—ovarian cancer	0.0126	0.0263	CbGbCtD
Venlafaxine—CYP3A4—Paclitaxel—ovarian cancer	0.0105	0.0218	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—ovarian cancer	0.00942	0.0196	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—ovarian cancer	0.00888	0.0184	CbGbCtD
Venlafaxine—CYP3A4—Docetaxel—ovarian cancer	0.00757	0.0157	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—ovarian cancer	0.00564	0.0117	CbGbCtD
Venlafaxine—NPY1R—myometrium—ovarian cancer	0.0029	0.101	CbGeAlD
Venlafaxine—NPY1R—uterine cervix—ovarian cancer	0.00225	0.0782	CbGeAlD
Venlafaxine—NPY1R—gonad—ovarian cancer	0.00189	0.0656	CbGeAlD
Venlafaxine—NPY1R—female reproductive system—ovarian cancer	0.00169	0.0586	CbGeAlD
Venlafaxine—NPY1R—vagina—ovarian cancer	0.00153	0.053	CbGeAlD
Venlafaxine—NPY1R—testis—ovarian cancer	0.00136	0.0473	CbGeAlD
Venlafaxine—NPY1R—lymph node—ovarian cancer	0.000988	0.0343	CbGeAlD
Venlafaxine—ABCG2—myometrium—ovarian cancer	0.000785	0.0273	CbGeAlD
Venlafaxine—SLC6A2—decidua—ovarian cancer	0.000729	0.0253	CbGeAlD
Venlafaxine—SLC6A4—female reproductive system—ovarian cancer	0.000651	0.0226	CbGeAlD
Venlafaxine—SLC6A2—gonad—ovarian cancer	0.000642	0.0223	CbGeAlD
Venlafaxine—ABCG2—uterine cervix—ovarian cancer	0.000611	0.0212	CbGeAlD
Venlafaxine—ABCG2—decidua—ovarian cancer	0.000582	0.0202	CbGeAlD
Venlafaxine—SLC6A3—testis—ovarian cancer	0.000573	0.0199	CbGeAlD
Venlafaxine—SLC6A2—female reproductive system—ovarian cancer	0.000573	0.0199	CbGeAlD
Venlafaxine—ABCG2—endometrium—ovarian cancer	0.000553	0.0192	CbGeAlD
Venlafaxine—ABCG2—uterus—ovarian cancer	0.000509	0.0177	CbGeAlD
Venlafaxine—CYP2C19—vagina—ovarian cancer	0.000488	0.0169	CbGeAlD
Venlafaxine—CYP2B6—gonad—ovarian cancer	0.000473	0.0164	CbGeAlD
Venlafaxine—SLC6A2—testis—ovarian cancer	0.000463	0.0161	CbGeAlD
Venlafaxine—ABCG2—bone marrow—ovarian cancer	0.000432	0.015	CbGeAlD
Venlafaxine—CYP2B6—female reproductive system—ovarian cancer	0.000422	0.0147	CbGeAlD
Venlafaxine—CYP2C9—female reproductive system—ovarian cancer	0.000418	0.0145	CbGeAlD
Venlafaxine—ABCG2—female gonad—ovarian cancer	0.000417	0.0145	CbGeAlD
Venlafaxine—ABCG2—vagina—ovarian cancer	0.000414	0.0144	CbGeAlD
Venlafaxine—ABCB1—myometrium—ovarian cancer	0.000387	0.0134	CbGeAlD
Venlafaxine—CYP2B6—vagina—ovarian cancer	0.000382	0.0133	CbGeAlD
Venlafaxine—ABCB1—embryo—ovarian cancer	0.000372	0.0129	CbGeAlD
Venlafaxine—ABCG2—testis—ovarian cancer	0.00037	0.0128	CbGeAlD
Venlafaxine—CYP2B6—testis—ovarian cancer	0.000341	0.0118	CbGeAlD
Venlafaxine—SLC6A2—lymph node—ovarian cancer	0.000335	0.0116	CbGeAlD
Venlafaxine—CYP3A4—female reproductive system—ovarian cancer	0.000319	0.0111	CbGeAlD
Venlafaxine—CYP2D6—female reproductive system—ovarian cancer	0.000314	0.0109	CbGeAlD
Venlafaxine—ABCB1—epithelium—ovarian cancer	0.000304	0.0106	CbGeAlD
Venlafaxine—ABCB1—uterine cervix—ovarian cancer	0.000301	0.0105	CbGeAlD
Venlafaxine—ABCB1—decidua—ovarian cancer	0.000287	0.00997	CbGeAlD
Venlafaxine—CYP2D6—female gonad—ovarian cancer	0.000286	0.00991	CbGeAlD
Venlafaxine—ABCB1—endometrium—ovarian cancer	0.000273	0.00946	CbGeAlD
Venlafaxine—ABCG2—lymph node—ovarian cancer	0.000268	0.0093	CbGeAlD
Venlafaxine—CYP2D6—testis—ovarian cancer	0.000253	0.00879	CbGeAlD
Venlafaxine—ABCB1—gonad—ovarian cancer	0.000253	0.00878	CbGeAlD
Venlafaxine—ABCB1—uterus—ovarian cancer	0.000251	0.00872	CbGeAlD
Venlafaxine—ABCB1—female reproductive system—ovarian cancer	0.000226	0.00784	CbGeAlD
Venlafaxine—ABCB1—bone marrow—ovarian cancer	0.000213	0.0074	CbGeAlD
Venlafaxine—ABCB1—female gonad—ovarian cancer	0.000205	0.00713	CbGeAlD
Venlafaxine—ABCB1—vagina—ovarian cancer	0.000204	0.00709	CbGeAlD
Venlafaxine—ABCB1—testis—ovarian cancer	0.000182	0.00633	CbGeAlD
Venlafaxine—ABCB1—lymph node—ovarian cancer	0.000132	0.00458	CbGeAlD
Venlafaxine—Insomnia—Paclitaxel—ovarian cancer	8.37e-05	0.000377	CcSEcCtD
Venlafaxine—Pneumonia—Epirubicin—ovarian cancer	8.34e-05	0.000376	CcSEcCtD
Venlafaxine—Convulsion—Docetaxel—ovarian cancer	8.32e-05	0.000375	CcSEcCtD
Venlafaxine—Paraesthesia—Paclitaxel—ovarian cancer	8.31e-05	0.000374	CcSEcCtD
Venlafaxine—Hypertension—Docetaxel—ovarian cancer	8.3e-05	0.000374	CcSEcCtD
Venlafaxine—Bronchitis—Doxorubicin—ovarian cancer	8.28e-05	0.000373	CcSEcCtD
Venlafaxine—Dyspnoea—Paclitaxel—ovarian cancer	8.25e-05	0.000372	CcSEcCtD
Venlafaxine—Somnolence—Paclitaxel—ovarian cancer	8.22e-05	0.000371	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	8.22e-05	0.000371	CcSEcCtD
Venlafaxine—Arthralgia—Docetaxel—ovarian cancer	8.18e-05	0.000369	CcSEcCtD
Venlafaxine—Chest pain—Docetaxel—ovarian cancer	8.18e-05	0.000369	CcSEcCtD
Venlafaxine—Myalgia—Docetaxel—ovarian cancer	8.18e-05	0.000369	CcSEcCtD
Venlafaxine—Pancytopenia—Doxorubicin—ovarian cancer	8.17e-05	0.000368	CcSEcCtD
Venlafaxine—Nausea—Vinorelbine—ovarian cancer	8.17e-05	0.000368	CcSEcCtD
Venlafaxine—Renal failure—Epirubicin—ovarian cancer	8.15e-05	0.000367	CcSEcCtD
Venlafaxine—Dyspepsia—Paclitaxel—ovarian cancer	8.14e-05	0.000367	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Epirubicin—ovarian cancer	8.13e-05	0.000366	CcSEcCtD
Venlafaxine—Stomatitis—Epirubicin—ovarian cancer	8.08e-05	0.000364	CcSEcCtD
Venlafaxine—Jaundice—Epirubicin—ovarian cancer	8.08e-05	0.000364	CcSEcCtD
Venlafaxine—Conjunctivitis—Epirubicin—ovarian cancer	8.06e-05	0.000363	CcSEcCtD
Venlafaxine—Neutropenia—Doxorubicin—ovarian cancer	8.05e-05	0.000363	CcSEcCtD
Venlafaxine—Dysuria—Doxorubicin—ovarian cancer	8.05e-05	0.000363	CcSEcCtD
Venlafaxine—Decreased appetite—Paclitaxel—ovarian cancer	8.04e-05	0.000362	CcSEcCtD
Venlafaxine—Dry mouth—Docetaxel—ovarian cancer	8e-05	0.000361	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	8e-05	0.00036	CcSEcCtD
Venlafaxine—Fatigue—Paclitaxel—ovarian cancer	7.98e-05	0.000359	CcSEcCtD
Venlafaxine—Sweating—Epirubicin—ovarian cancer	7.95e-05	0.000358	CcSEcCtD
Venlafaxine—Pollakiuria—Doxorubicin—ovarian cancer	7.95e-05	0.000358	CcSEcCtD
Venlafaxine—Pain—Paclitaxel—ovarian cancer	7.91e-05	0.000357	CcSEcCtD
Venlafaxine—Constipation—Paclitaxel—ovarian cancer	7.91e-05	0.000357	CcSEcCtD
Venlafaxine—Haematuria—Epirubicin—ovarian cancer	7.91e-05	0.000356	CcSEcCtD
Venlafaxine—Confusional state—Docetaxel—ovarian cancer	7.91e-05	0.000356	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Doxorubicin—ovarian cancer	7.86e-05	0.000354	CcSEcCtD
Venlafaxine—Anaphylactic shock—Docetaxel—ovarian cancer	7.84e-05	0.000353	CcSEcCtD
Venlafaxine—Oedema—Docetaxel—ovarian cancer	7.84e-05	0.000353	CcSEcCtD
Venlafaxine—Weight increased—Doxorubicin—ovarian cancer	7.83e-05	0.000353	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—ovarian cancer	7.82e-05	0.000353	CcSEcCtD
Venlafaxine—Infection—Docetaxel—ovarian cancer	7.79e-05	0.000351	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—ovarian cancer	7.79e-05	0.000351	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—ovarian cancer	7.78e-05	0.000351	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—ovarian cancer	7.76e-05	0.00035	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—ovarian cancer	7.74e-05	0.000349	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—ovarian cancer	7.72e-05	0.000348	CcSEcCtD
Venlafaxine—Shock—Docetaxel—ovarian cancer	7.71e-05	0.000348	CcSEcCtD
Venlafaxine—Thrombocytopenia—Docetaxel—ovarian cancer	7.68e-05	0.000346	CcSEcCtD
Venlafaxine—Tachycardia—Docetaxel—ovarian cancer	7.65e-05	0.000345	CcSEcCtD
Venlafaxine—Feeling abnormal—Paclitaxel—ovarian cancer	7.62e-05	0.000344	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.61e-05	0.000343	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—ovarian cancer	7.58e-05	0.000342	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.57e-05	0.000341	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—ovarian cancer	7.54e-05	0.00034	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.52e-05	0.000339	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—ovarian cancer	7.48e-05	0.000337	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—ovarian cancer	7.48e-05	0.000337	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—ovarian cancer	7.48e-05	0.000337	CcSEcCtD
Venlafaxine—Anorexia—Docetaxel—ovarian cancer	7.47e-05	0.000337	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—ovarian cancer	7.46e-05	0.000336	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—ovarian cancer	7.46e-05	0.000336	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—ovarian cancer	7.44e-05	0.000336	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—ovarian cancer	7.44e-05	0.000336	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—ovarian cancer	7.41e-05	0.000334	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—ovarian cancer	7.39e-05	0.000333	CcSEcCtD
Venlafaxine—Sweating—Doxorubicin—ovarian cancer	7.36e-05	0.000332	CcSEcCtD
Venlafaxine—Urticaria—Paclitaxel—ovarian cancer	7.35e-05	0.000331	CcSEcCtD
Venlafaxine—Hypotension—Docetaxel—ovarian cancer	7.33e-05	0.00033	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—ovarian cancer	7.32e-05	0.00033	CcSEcCtD
Venlafaxine—Abdominal pain—Paclitaxel—ovarian cancer	7.31e-05	0.00033	CcSEcCtD
Venlafaxine—Body temperature increased—Paclitaxel—ovarian cancer	7.31e-05	0.00033	CcSEcCtD
Venlafaxine—Epistaxis—Doxorubicin—ovarian cancer	7.24e-05	0.000326	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—ovarian cancer	7.2e-05	0.000324	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—ovarian cancer	7.17e-05	0.000323	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—ovarian cancer	7.16e-05	0.000323	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	7.14e-05	0.000322	CcSEcCtD
Venlafaxine—Insomnia—Docetaxel—ovarian cancer	7.09e-05	0.00032	CcSEcCtD
Venlafaxine—Paraesthesia—Docetaxel—ovarian cancer	7.04e-05	0.000317	CcSEcCtD
Venlafaxine—Erythema multiforme—Epirubicin—ovarian cancer	7.04e-05	0.000317	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—ovarian cancer	7.01e-05	0.000316	CcSEcCtD
Venlafaxine—Dyspnoea—Docetaxel—ovarian cancer	6.99e-05	0.000315	CcSEcCtD
Venlafaxine—Somnolence—Docetaxel—ovarian cancer	6.97e-05	0.000314	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—ovarian cancer	6.94e-05	0.000313	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—ovarian cancer	6.92e-05	0.000312	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—ovarian cancer	6.91e-05	0.000311	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—ovarian cancer	6.91e-05	0.000311	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—ovarian cancer	6.91e-05	0.000311	CcSEcCtD
Venlafaxine—Dyspepsia—Docetaxel—ovarian cancer	6.9e-05	0.000311	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—ovarian cancer	6.89e-05	0.00031	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—ovarian cancer	6.89e-05	0.00031	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—ovarian cancer	6.85e-05	0.000309	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—ovarian cancer	6.84e-05	0.000308	CcSEcCtD
Venlafaxine—Decreased appetite—Docetaxel—ovarian cancer	6.82e-05	0.000307	CcSEcCtD
Venlafaxine—Hypersensitivity—Paclitaxel—ovarian cancer	6.82e-05	0.000307	CcSEcCtD
Venlafaxine—Fatigue—Docetaxel—ovarian cancer	6.76e-05	0.000305	CcSEcCtD
Venlafaxine—Pain—Docetaxel—ovarian cancer	6.71e-05	0.000302	CcSEcCtD
Venlafaxine—Constipation—Docetaxel—ovarian cancer	6.71e-05	0.000302	CcSEcCtD
Venlafaxine—Chills—Epirubicin—ovarian cancer	6.68e-05	0.000301	CcSEcCtD
Venlafaxine—Arrhythmia—Epirubicin—ovarian cancer	6.65e-05	0.0003	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—ovarian cancer	6.64e-05	0.000299	CcSEcCtD
Venlafaxine—Asthenia—Paclitaxel—ovarian cancer	6.64e-05	0.000299	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—ovarian cancer	6.58e-05	0.000296	CcSEcCtD
Venlafaxine—Pruritus—Paclitaxel—ovarian cancer	6.55e-05	0.000295	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—ovarian cancer	6.51e-05	0.000294	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—ovarian cancer	6.48e-05	0.000292	CcSEcCtD
Venlafaxine—Feeling abnormal—Docetaxel—ovarian cancer	6.46e-05	0.000291	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—ovarian cancer	6.42e-05	0.000289	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Docetaxel—ovarian cancer	6.41e-05	0.000289	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—ovarian cancer	6.39e-05	0.000288	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—ovarian cancer	6.39e-05	0.000288	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—ovarian cancer	6.39e-05	0.000288	CcSEcCtD
Venlafaxine—Tension—Epirubicin—ovarian cancer	6.36e-05	0.000287	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—ovarian cancer	6.35e-05	0.000286	CcSEcCtD
Venlafaxine—Diarrhoea—Paclitaxel—ovarian cancer	6.33e-05	0.000285	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—ovarian cancer	6.29e-05	0.000284	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—ovarian cancer	6.27e-05	0.000283	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—ovarian cancer	6.23e-05	0.000281	CcSEcCtD
Venlafaxine—Abdominal pain—Docetaxel—ovarian cancer	6.2e-05	0.000279	CcSEcCtD
Venlafaxine—Body temperature increased—Docetaxel—ovarian cancer	6.2e-05	0.000279	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—ovarian cancer	6.18e-05	0.000279	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—ovarian cancer	6.15e-05	0.000277	CcSEcCtD
Venlafaxine—Dizziness—Paclitaxel—ovarian cancer	6.12e-05	0.000276	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—ovarian cancer	6.11e-05	0.000275	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—ovarian cancer	6.09e-05	0.000274	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—ovarian cancer	6.01e-05	0.000271	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—ovarian cancer	6e-05	0.00027	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—ovarian cancer	5.99e-05	0.00027	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—ovarian cancer	5.96e-05	0.000268	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—ovarian cancer	5.91e-05	0.000266	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—ovarian cancer	5.88e-05	0.000265	CcSEcCtD
Venlafaxine—Vomiting—Paclitaxel—ovarian cancer	5.88e-05	0.000265	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—ovarian cancer	5.87e-05	0.000265	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—ovarian cancer	5.84e-05	0.000263	CcSEcCtD
Venlafaxine—Rash—Paclitaxel—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Venlafaxine—Dermatitis—Paclitaxel—ovarian cancer	5.83e-05	0.000263	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—ovarian cancer	5.82e-05	0.000262	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—ovarian cancer	5.82e-05	0.000262	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—ovarian cancer	5.81e-05	0.000262	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—ovarian cancer	5.8e-05	0.000261	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—ovarian cancer	5.8e-05	0.000261	CcSEcCtD
Venlafaxine—Headache—Paclitaxel—ovarian cancer	5.8e-05	0.000261	CcSEcCtD
Venlafaxine—Hypersensitivity—Docetaxel—ovarian cancer	5.78e-05	0.00026	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—ovarian cancer	5.77e-05	0.00026	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—ovarian cancer	5.73e-05	0.000258	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—ovarian cancer	5.7e-05	0.000257	CcSEcCtD
Venlafaxine—Cough—Epirubicin—ovarian cancer	5.66e-05	0.000255	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—ovarian cancer	5.65e-05	0.000255	CcSEcCtD
Venlafaxine—Asthenia—Docetaxel—ovarian cancer	5.63e-05	0.000254	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—ovarian cancer	5.62e-05	0.000253	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—ovarian cancer	5.6e-05	0.000252	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—ovarian cancer	5.56e-05	0.000251	CcSEcCtD
Venlafaxine—Pruritus—Docetaxel—ovarian cancer	5.55e-05	0.00025	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—ovarian cancer	5.54e-05	0.00025	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—ovarian cancer	5.52e-05	0.000249	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—ovarian cancer	5.52e-05	0.000249	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—ovarian cancer	5.52e-05	0.000249	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—ovarian cancer	5.51e-05	0.000248	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—ovarian cancer	5.5e-05	0.000248	CcSEcCtD
Venlafaxine—Nausea—Paclitaxel—ovarian cancer	5.5e-05	0.000248	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—ovarian cancer	5.45e-05	0.000246	CcSEcCtD
Venlafaxine—Malaise—Doxorubicin—ovarian cancer	5.41e-05	0.000244	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—ovarian cancer	5.4e-05	0.000243	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—ovarian cancer	5.39e-05	0.000243	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—ovarian cancer	5.38e-05	0.000242	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—ovarian cancer	5.37e-05	0.000242	CcSEcCtD
Venlafaxine—Diarrhoea—Docetaxel—ovarian cancer	5.37e-05	0.000242	CcSEcCtD
Venlafaxine—Confusional state—Epirubicin—ovarian cancer	5.33e-05	0.00024	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—ovarian cancer	5.3e-05	0.000239	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—ovarian cancer	5.29e-05	0.000238	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—ovarian cancer	5.29e-05	0.000238	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—ovarian cancer	5.27e-05	0.000238	CcSEcCtD
Venlafaxine—Infection—Epirubicin—ovarian cancer	5.25e-05	0.000237	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—ovarian cancer	5.23e-05	0.000236	CcSEcCtD
Venlafaxine—Shock—Epirubicin—ovarian cancer	5.2e-05	0.000235	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—ovarian cancer	5.2e-05	0.000234	CcSEcCtD
Venlafaxine—Dizziness—Docetaxel—ovarian cancer	5.19e-05	0.000234	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—ovarian cancer	5.18e-05	0.000233	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—ovarian cancer	5.18e-05	0.000233	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—ovarian cancer	5.16e-05	0.000233	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—ovarian cancer	5.11e-05	0.00023	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—ovarian cancer	5.11e-05	0.00023	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—ovarian cancer	5.11e-05	0.00023	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—ovarian cancer	5.11e-05	0.00023	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—ovarian cancer	5.09e-05	0.000229	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—ovarian cancer	5.04e-05	0.000227	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—ovarian cancer	5.04e-05	0.000227	CcSEcCtD
Venlafaxine—Dry mouth—Doxorubicin—ovarian cancer	4.99e-05	0.000225	CcSEcCtD
Venlafaxine—Vomiting—Docetaxel—ovarian cancer	4.99e-05	0.000225	CcSEcCtD
Venlafaxine—Rash—Docetaxel—ovarian cancer	4.94e-05	0.000223	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—ovarian cancer	4.94e-05	0.000223	CcSEcCtD
Venlafaxine—Dermatitis—Docetaxel—ovarian cancer	4.94e-05	0.000223	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—ovarian cancer	4.93e-05	0.000222	CcSEcCtD
Venlafaxine—Headache—Docetaxel—ovarian cancer	4.91e-05	0.000221	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—ovarian cancer	4.89e-05	0.000221	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—ovarian cancer	4.89e-05	0.000221	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—ovarian cancer	4.86e-05	0.000219	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.82e-05	0.000217	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—ovarian cancer	4.81e-05	0.000217	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—ovarian cancer	4.79e-05	0.000216	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—ovarian cancer	4.78e-05	0.000216	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—ovarian cancer	4.78e-05	0.000215	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—ovarian cancer	4.75e-05	0.000214	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—ovarian cancer	4.73e-05	0.000213	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—ovarian cancer	4.72e-05	0.000213	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—ovarian cancer	4.7e-05	0.000212	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—ovarian cancer	4.66e-05	0.00021	CcSEcCtD
Venlafaxine—Nausea—Docetaxel—ovarian cancer	4.66e-05	0.00021	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—ovarian cancer	4.66e-05	0.00021	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—ovarian cancer	4.6e-05	0.000207	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—ovarian cancer	4.57e-05	0.000206	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—ovarian cancer	4.56e-05	0.000206	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—ovarian cancer	4.52e-05	0.000204	CcSEcCtD
Venlafaxine—Pain—Epirubicin—ovarian cancer	4.52e-05	0.000204	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.46e-05	0.000201	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—ovarian cancer	4.43e-05	0.000199	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—ovarian cancer	4.39e-05	0.000198	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—ovarian cancer	4.36e-05	0.000197	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—ovarian cancer	4.36e-05	0.000196	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—ovarian cancer	4.35e-05	0.000196	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—ovarian cancer	4.33e-05	0.000195	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—ovarian cancer	4.31e-05	0.000194	CcSEcCtD
Venlafaxine—Decreased appetite—Doxorubicin—ovarian cancer	4.25e-05	0.000192	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—ovarian cancer	4.22e-05	0.00019	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—ovarian cancer	4.2e-05	0.000189	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—ovarian cancer	4.18e-05	0.000189	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—ovarian cancer	4.18e-05	0.000189	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—ovarian cancer	4.18e-05	0.000188	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—ovarian cancer	4.18e-05	0.000188	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—ovarian cancer	4.03e-05	0.000182	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Doxorubicin—ovarian cancer	4e-05	0.00018	CcSEcCtD
Venlafaxine—Hypersensitivity—Epirubicin—ovarian cancer	3.9e-05	0.000176	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—ovarian cancer	3.89e-05	0.000175	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—ovarian cancer	3.87e-05	0.000174	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—ovarian cancer	3.87e-05	0.000174	CcSEcCtD
Venlafaxine—Asthenia—Epirubicin—ovarian cancer	3.79e-05	0.000171	CcSEcCtD
Venlafaxine—Pruritus—Epirubicin—ovarian cancer	3.74e-05	0.000169	CcSEcCtD
Venlafaxine—Diarrhoea—Epirubicin—ovarian cancer	3.62e-05	0.000163	CcSEcCtD
Venlafaxine—Hypersensitivity—Doxorubicin—ovarian cancer	3.61e-05	0.000163	CcSEcCtD
Venlafaxine—Asthenia—Doxorubicin—ovarian cancer	3.51e-05	0.000158	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—ovarian cancer	3.5e-05	0.000158	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—ovarian cancer	3.46e-05	0.000156	CcSEcCtD
Venlafaxine—Vomiting—Epirubicin—ovarian cancer	3.36e-05	0.000152	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—ovarian cancer	3.35e-05	0.000151	CcSEcCtD
Venlafaxine—Rash—Epirubicin—ovarian cancer	3.33e-05	0.00015	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—ovarian cancer	3.33e-05	0.00015	CcSEcCtD
Venlafaxine—Headache—Epirubicin—ovarian cancer	3.31e-05	0.000149	CcSEcCtD
Venlafaxine—Dizziness—Doxorubicin—ovarian cancer	3.24e-05	0.000146	CcSEcCtD
Venlafaxine—Nausea—Epirubicin—ovarian cancer	3.14e-05	0.000142	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.14e-05	0.00119	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.14e-05	0.00119	CbGpPWpGaD
Venlafaxine—Vomiting—Doxorubicin—ovarian cancer	3.11e-05	0.00014	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PPP2R1A—ovarian cancer	3.1e-05	0.00117	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CD—ovarian cancer	3.09e-05	0.00117	CbGpPWpGaD
Venlafaxine—Rash—Doxorubicin—ovarian cancer	3.09e-05	0.000139	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—ovarian cancer	3.08e-05	0.000139	CcSEcCtD
Venlafaxine—Headache—Doxorubicin—ovarian cancer	3.07e-05	0.000138	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—NME2—ovarian cancer	3e-05	0.00114	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CB—ovarian cancer	2.97e-05	0.00112	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.96e-05	0.00112	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—ovarian cancer	2.91e-05	0.000131	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.88e-05	0.00109	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.87e-05	0.00109	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL8—ovarian cancer	2.85e-05	0.00108	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.84e-05	0.00107	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.83e-05	0.00107	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.83e-05	0.00107	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.83e-05	0.00107	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.78e-05	0.00105	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.77e-05	0.00105	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.75e-05	0.00104	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—ovarian cancer	2.72e-05	0.00103	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.71e-05	0.00103	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.7e-05	0.00102	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CB—ovarian cancer	2.69e-05	0.00102	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.65e-05	0.001	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYTB—ovarian cancer	2.64e-05	0.000999	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.61e-05	0.00099	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—ovarian cancer	2.59e-05	0.00098	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.56e-05	0.000968	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.54e-05	0.000964	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.48e-05	0.000938	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—ovarian cancer	2.47e-05	0.000936	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TERT—ovarian cancer	2.46e-05	0.000933	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.4e-05	0.000909	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—BRIP1—ovarian cancer	2.31e-05	0.000873	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPP1CC—ovarian cancer	2.31e-05	0.000873	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CAV1—ovarian cancer	2.28e-05	0.000863	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—ovarian cancer	2.27e-05	0.00086	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NME2—ovarian cancer	2.27e-05	0.000859	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.24e-05	0.000847	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NME2—ovarian cancer	2.21e-05	0.000838	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.21e-05	0.000835	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ESR1—ovarian cancer	2.2e-05	0.000832	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.2e-05	0.000831	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6ST—ovarian cancer	2.16e-05	0.000818	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.15e-05	0.000812	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.1e-05	0.000794	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NME2—ovarian cancer	2.09e-05	0.00079	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—ovarian cancer	2.08e-05	0.000787	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CG—ovarian cancer	2.08e-05	0.000786	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—APC—ovarian cancer	2.08e-05	0.000786	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—NRAS—ovarian cancer	2.08e-05	0.000786	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.07e-05	0.000783	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NME2—ovarian cancer	2.07e-05	0.000783	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.02e-05	0.000764	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—MAPK3—ovarian cancer	1.99e-05	0.000753	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.98e-05	0.00075	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYTB—ovarian cancer	1.93e-05	0.000732	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.92e-05	0.000728	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—MAPK1—ovarian cancer	1.89e-05	0.000716	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—ovarian cancer	1.89e-05	0.000716	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CD—ovarian cancer	1.83e-05	0.000691	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CA—ovarian cancer	1.81e-05	0.000685	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KRAS—ovarian cancer	1.79e-05	0.000677	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.77e-05	0.00067	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.75e-05	0.000664	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.69e-05	0.00064	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.69e-05	0.00064	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.66e-05	0.000629	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CA—ovarian cancer	1.64e-05	0.000622	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—ovarian cancer	1.61e-05	0.00061	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MTOR—ovarian cancer	1.59e-05	0.000602	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CB—ovarian cancer	1.59e-05	0.000602	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—MAPK1—ovarian cancer	1.58e-05	0.0006	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.57e-05	0.000594	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—YAP1—ovarian cancer	1.55e-05	0.000586	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.54e-05	0.000583	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—ovarian cancer	1.53e-05	0.000579	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—ovarian cancer	1.52e-05	0.000575	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDKN1B—ovarian cancer	1.49e-05	0.000565	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—ovarian cancer	1.48e-05	0.000559	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP3—ovarian cancer	1.46e-05	0.000554	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYTB—ovarian cancer	1.46e-05	0.000553	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—ovarian cancer	1.46e-05	0.000553	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—ovarian cancer	1.45e-05	0.00055	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.43e-05	0.000542	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.43e-05	0.000541	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.43e-05	0.000541	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYTB—ovarian cancer	1.43e-05	0.00054	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.42e-05	0.00054	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—ovarian cancer	1.42e-05	0.000539	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CTNNB1—ovarian cancer	1.41e-05	0.000534	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.4e-05	0.000529	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—ovarian cancer	1.38e-05	0.000524	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.38e-05	0.000523	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—ovarian cancer	1.37e-05	0.000521	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NME2—ovarian cancer	1.36e-05	0.000516	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.36e-05	0.000515	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.35e-05	0.00051	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYTB—ovarian cancer	1.34e-05	0.000509	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—ovarian cancer	1.34e-05	0.000508	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYTB—ovarian cancer	1.33e-05	0.000504	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.31e-05	0.000497	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.3e-05	0.000493	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.28e-05	0.000484	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.28e-05	0.000484	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—ovarian cancer	1.27e-05	0.000482	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—FASN—ovarian cancer	1.26e-05	0.000477	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.25e-05	0.000472	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.25e-05	0.000472	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—ovarian cancer	1.24e-05	0.00047	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.24e-05	0.00047	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—ovarian cancer	1.23e-05	0.000466	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NRAS—ovarian cancer	1.23e-05	0.000464	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.2e-05	0.000453	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.18e-05	0.000449	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.17e-05	0.000445	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.17e-05	0.000445	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK3—ovarian cancer	1.17e-05	0.000445	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.16e-05	0.000441	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.16e-05	0.000441	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.15e-05	0.000435	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—ovarian cancer	1.14e-05	0.000433	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—YAP1—ovarian cancer	1.13e-05	0.000429	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.12e-05	0.000424	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK1—ovarian cancer	1.12e-05	0.000423	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—ovarian cancer	1.12e-05	0.000423	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.09e-05	0.000413	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.07e-05	0.000404	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.07e-05	0.000404	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KRAS—ovarian cancer	1.06e-05	0.0004	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.02e-05	0.000386	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.01e-05	0.000381	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—ovarian cancer	9.7e-06	0.000367	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ABCB1—ovarian cancer	9.45e-06	0.000358	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—ovarian cancer	9.38e-06	0.000355	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.31e-06	0.000352	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMS—ovarian cancer	9.29e-06	0.000352	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.26e-06	0.00035	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—FASN—ovarian cancer	9.24e-06	0.00035	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	9.09e-06	0.000344	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—ovarian cancer	8.97e-06	0.00034	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.95e-06	0.000339	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYTB—ovarian cancer	8.79e-06	0.000333	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	8.78e-06	0.000332	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—ovarian cancer	8.59e-06	0.000325	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—YAP1—ovarian cancer	8.57e-06	0.000324	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.49e-06	0.000321	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.48e-06	0.000321	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	8.42e-06	0.000319	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—YAP1—ovarian cancer	8.36e-06	0.000317	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—ovarian cancer	7.92e-06	0.0003	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—YAP1—ovarian cancer	7.88e-06	0.000298	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—YAP1—ovarian cancer	7.81e-06	0.000296	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.73e-06	0.000293	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.68e-06	0.000291	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.68e-06	0.000291	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.56e-06	0.000286	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CAV1—ovarian cancer	7.48e-06	0.000283	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	7.46e-06	0.000283	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.45e-06	0.000282	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—FASN—ovarian cancer	6.98e-06	0.000264	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ABCB1—ovarian cancer	6.93e-06	0.000262	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.87e-06	0.00026	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—FASN—ovarian cancer	6.82e-06	0.000258	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.82e-06	0.000258	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMS—ovarian cancer	6.81e-06	0.000258	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.79e-06	0.000257	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.7e-06	0.000254	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.63e-06	0.000251	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.5e-06	0.000246	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.47e-06	0.000245	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—FASN—ovarian cancer	6.42e-06	0.000243	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—FASN—ovarian cancer	6.37e-06	0.000241	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.36e-06	0.000241	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6.32e-06	0.000239	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.26e-06	0.000237	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.21e-06	0.000235	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.1e-06	0.000231	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.05e-06	0.000229	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CD—ovarian cancer	5.99e-06	0.000227	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.92e-06	0.000224	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.85e-06	0.000221	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.8e-06	0.00022	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.64e-06	0.000214	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.61e-06	0.000213	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.51e-06	0.000208	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CAV1—ovarian cancer	5.48e-06	0.000208	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.24e-06	0.000198	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.22e-06	0.000198	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.19e-06	0.000196	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—YAP1—ovarian cancer	5.15e-06	0.000195	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMS—ovarian cancer	5.14e-06	0.000195	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.14e-06	0.000195	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.12e-06	0.000194	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMS—ovarian cancer	5.02e-06	0.00019	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	5e-06	0.000189	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.82e-06	0.000182	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.78e-06	0.000181	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMS—ovarian cancer	4.73e-06	0.000179	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMS—ovarian cancer	4.69e-06	0.000178	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—ovarian cancer	4.51e-06	0.000171	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.39e-06	0.000166	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—FASN—ovarian cancer	4.2e-06	0.000159	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CAV1—ovarian cancer	4.14e-06	0.000157	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.13e-06	0.000156	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CAV1—ovarian cancer	4.05e-06	0.000153	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.99e-06	0.000151	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.96e-06	0.00015	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.83e-06	0.000145	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.82e-06	0.000145	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.81e-06	0.000144	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CAV1—ovarian cancer	3.78e-06	0.000143	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.78e-06	0.000143	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.68e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.61e-06	0.000137	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.47e-06	0.000131	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.44e-06	0.00013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.39e-06	0.000128	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.32e-06	0.000126	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—ovarian cancer	3.31e-06	0.000125	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.24e-06	0.000123	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.18e-06	0.000121	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.15e-06	0.000119	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.09e-06	0.000117	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.05e-06	0.000116	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.03e-06	0.000115	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.89e-06	0.00011	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.82e-06	0.000107	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.66e-06	0.000101	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.64e-06	9.99e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—ovarian cancer	2.6e-06	9.85e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—ovarian cancer	2.5e-06	9.46e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.49e-06	9.44e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—ovarian cancer	2.44e-06	9.24e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.33e-06	8.84e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.3e-06	8.71e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—ovarian cancer	2.28e-06	8.63e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.27e-06	8.6e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2e-06	7.56e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—ovarian cancer	1.91e-06	7.22e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.76e-06	6.68e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.74e-06	6.59e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.72e-06	6.52e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.62e-06	6.14e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.61e-06	6.09e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.5e-06	5.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—ovarian cancer	1.44e-06	5.45e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—ovarian cancer	1.41e-06	5.32e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.32e-06	5.02e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.31e-06	4.97e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.06e-06	4.02e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—ovarian cancer	8.66e-07	3.28e-05	CbGpPWpGaD
